The EMRA offices will be closed for the upcoming holidays from Tuesday, December 24, 2024 thru Wednesday, January 1, 2025. We apologize for the inconvenience.
Mechanical circulatory devices continue to evolve, allowing greater support of the sickest patients. This article discusses the Impella heart pumps, developed to address high-risk percutaneous coronar
The use of extracorporeal membrane oxygenation - ECMO - as an adjunct to CPR following out-of-hospital cardiac arrest has gained a lot of attention. The INCEPTION Trial takes a closer look at the evid
Post-resuscitation shock occurs in 50-70% of patients after out-of-hospital cardiac arrest, and this study provides evidence that norepinephrine is likely a preferable vasopressor to epinephrine in po
Few patients who suffer cardiac arrest from massive pulmonary embolism will survive to hospital discharge. From the evidence available, there is no clear mortality or functional outcome benefit to any
One study showed short-term benefit to using vasopressin and methylprednisolone in patients who experience in-hospital cardiac arrest. But study limitations mean further examination is needed before a
Anaphylaxis is a severe life-threatening acute systemic type 1 hypersensitivity reaction. This IgE-mediated reaction leads to varying degrees of mast-cell degranulation, histamine release and varying
Managing critically ill patients with cardiogenic shock often includes a decision between two inotropes: dobutamine and milrinone. Is there evidence to inform that choice?
Evidence surrounding the benefits of post-arrest hypothermia has been conflicting, but it continues to be the standard of care per international guidelines. The TTM2 Trial adds to the data.